Dec 11, 2010 - 5:46 am
I am myself an IMRT beneficiary and have been recommending the treatment to friends because of its good results and minor side effects. This article in the Wall Street Journal is shock-ing in regards of its use in USA for the benefit of someone’s pocket, independently of patient need. Is that true? Here in Europe it may be difficult such practice but the future is unpredictable. It says; “…Roughly one in three Medicare beneficiaries diagnosed with prostate cancer today gets a sophisticated form of radiation therapy called IMRT. Eight years ago, virtually no patients received the treatment. The story behind the sharp rise in the use of IMRT—which stands for intensity-modulated radiation therapy—is about more than just the rapid adoption of a new medical technology. It's also about financial incentives.”
Hope that does not influence the patient group.